SYL-1801

N/A

Report date: 2024/05/15 16:09:07
NME

Base Information

Drug NameSYL-1801
Drug Alias NameSYL-1801SYL-040003SYL-054003
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceNotch-regulated ankyrin repeat-containing protein inhibitors
TargetsNotch-regulated ankyrin repeat-containing protein
Therapy Area/IndicationsChoroidal NeovascularizationWet age-related macular degenerationMacular Degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSlovakiaPoland +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSylentis Sa
China Registration ClassN/A

Develop Information

Active CompaniesSylentis Sa
Inactive CompaniesN/A
Active IndicationsChoroidal NeovascularizationWet age-related macular degenerationMacular Degeneration
Inactive IndicationsGlaucoma +[2] 

Other Information

ATC CodeN/A
Related LinksN/A